title: Monte-Carlo Simulation to Estimate the Health Care Costs Avoided With Fluticasone Furoate/Vilanterol Due to Exacerbation Rate Reduction in Spanish COPD Patients.
authors.affiliation: Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Mayoralas
authors.affiliation: GlaxoSmithKline, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Huerta
authors.affiliation: GlaxoSmithKline, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Parrondo
authors.affiliation: Health Value, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Rubio-Terrés
authors.affiliation: Health Value, Madrid, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Rubio-Rodríguez